Guest guest Posted November 21, 2003 Report Share Posted November 21, 2003 JustSayNo Thu, 20 Nov 2003 10:01:33 -0500 [sSRI-Research] Very Important Information from the UK regarding Paxil ADRs FYI: The Yellow Card Reporting System in the United Kingdom is comparable to the MedWatch Reporting System here in the United States " Charles Medawar " Analysis of paroxetine Yellow Card adverse drug reaction reports (Seroxat/Paxil) Wed, 19 Nov 2003 20:05:47 -0000 I have just posted on our website a copy of a paper on this subject published today in the International Journal of Risk and Safety of Medicine. See http://www.socialaudit.org.uk/5100what.htm#5.1 This paper (Medawar & Herxheimer, 2003) is the first analysis of its kind: it reveals new information both about paroxetine and the Yellow Card drug safety system. A summary of the main points appears below: International Journal of Risk & Safety in Medicine 16 (2003/2004) 5-19 A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine Charles Medawar (Social Audit Ltd., London, UK) and Andrew Herxheimer FRCP (DIPEx Project, Department of Primary Health Care, University of Oxford, Oxford, UK) Summary points 1. This report is unique in two different ways: · It is the first published critical appraisal of the role of spontaneous adverse drug reaction (ADR) reports in monitoring the safety of marketed medicines - the MHRA/CSM Yellow Card scheme is regarded " as the cornerstone of the Agency's work on medicines safety monitoring. " · This is also the first review of anonymised Yellow Card reports of suspected adverse drug reactions to paroxetine, relating to withdrawal reactions/dependence and suicidal behaviour. This report compares the value of ADR reports from drug users and health professionals. 2. This report produces new evidence of several different kinds: · It suggests that miscoding and flawed analyses of Yellow Cards have led to under-estimation of the risk of suicidal behaviour; · It reveals that most Yellow Cards lack important information (e.g. patient history, dosage; outcome of reaction); · It shows that the UK regulators have systematically failed to follow up reports of suicidal behaviour, in spite of conducting several reviews; · It suggests that poor reporting and data processing have impeded recognition of what appears to be a close relationship between suicidal behaviour and changes in drug concentration. An increased risk of suicidal behaviour during the first few days of treatment with an SSRI has long been suspected - but comparable risks seem to exist when drug dosages are either increased or lowered (during withdrawal). · It suggests that SSRI dosages may be far too high for some users · It gives evidence that ADR reports sent in by drug manufacturers systematically use euphemisms in describing ADRs (e.g. 'Non-accidental overdose' to describe suicide attempts) that help to obscure the true nature of risk; 3. We suggest that, although the Yellow Card is widely recognised as one of the best in the world it is, in important respects, " chaotic and misconceived " . Its value is limited by the emphasis on numbers not words; the focus on rare and 'interesting' ADRs, rather than the generality of drug-induced problems; secrecy that obstructs wider access to anonymised data; and lack of input from drug users themselves. 4. Our analyses suggest that reports from patients - in their own words - communicate essential information which professional reporters can never be expected to provide. We believe that patient reports of suspected ADRs can never credibly be ignored again. 5. We have submitted this and other evidence to the on-going review of the Yellow Card Scheme, under Dr Jeremy Metters of the UK Department of Health. I hope this is of interest Charles Medawar Social Audit Ltd P.O. Box 111 London NW1 8XG UK TEL/FAX +44 (0)20 7586 7771 http://www.socialaudit.org.uk NEW WEB MESSAGE BOARDS - JOIN HERE. Alternative Medicine Message Boards.Info http://alternative-medicine-message-boards.info Free Pop-Up Blocker - Get it now Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.